Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

Price is unknown


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Equity (BVPS) 4.30
5.31
5.73
6.75
9.24
9.96
10.44
12.07
11.57
19.15
growth rate 23.5% 7.9% 17.8% 36.9% 7.8% 4.8% 15.6% -4.1% 65.5%
Earnings BIT 39.00
40.63
73.61
147.25
87.84
108.45
79.34
18.88
49.78
56.60
growth rate 4.2% 81.2% 100.1% -40.4% 23.5% -26.8% -76.2% 163.7% 13.7%
Avg.PE 18.21
19.64
40.58
47.94
17.02
40.51
21.64
65.52
92.49
43.15
growth rate 7.9% 106.6% 18.1% -64.5% 138.0% -46.6% 202.8% 41.2% -53.4%
ROA 12.30
10.87
17.57
27.50
13.95
15.96
11.19
3.44
5.10
growth rate -11.6% 61.6% 56.5% -49.3% 14.4% -29.9% -69.3% 48.3%
ROE 27.10
25.14
39.26
64.28
33.17
37.80
26.72
7.07
8.44
growth rate -7.2% 56.2% 63.7% -48.4% 14.0% -29.3% -73.5% 19.4%
ROIC 18.00
15.98
27.60
49.32
25.28
27.19
18.84
5.90
7.56
growth rate -11.2% 72.7% 78.7% -48.7% 7.6% -30.7% -68.7% 28.1%
Cur. Ratio 2.75
2.26
1.63
1.53
1.81
1.73
2.03
2.28
2.23
growth rate -17.8% -27.9% -6.1% 18.3% -4.4% 17.3% 12.3% -2.2%
Quick Ratio 1.81
1.54
1.25
0.90
1.17
1.07
1.12
1.08
1.24
growth rate -14.9% -18.8% -28.0% 30.0% -8.6% 4.7% -3.6% 14.8%
Leverage 2.36
2.27
2.21
2.43
2.32
2.41
2.37
1.84
1.50
growth rate -3.8% -2.6% 10.0% -4.5% 3.9% -1.7% -22.4% -18.5%
Balance Sheet Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Acct.Receivable 64.00
70.57
107.08
134.64
132.15
150.79
143.88
93.35
120.75
121.48
growth rate 10.3% 51.7% 25.7% -1.9% 14.1% -4.6% -35.1% 29.3% 0.6%
Acct.Payable 23.00
25.93
52.84
102.10
75.82
98.72
79.36
46.41
63.61
71.50
growth rate 12.7% 103.8% 93.2% -25.7% 30.2% -19.6% -41.5% 37.1% 12.4%
Cur.Assets 124.00
131.38
187.84
294.62
258.66
302.51
308.22
303.36
321.63
374.45
growth rate 6.0% 43.0% 56.9% -12.2% 17.0% 1.9% -1.6% 6.0% 16.4%
Total Assets 231.00
236.59
293.41
443.36
412.17
464.85
493.62
550.83
549.18
590.83
growth rate 2.4% 24.0% 51.1% -7.0% 12.8% 6.2% 11.6% -0.3% 7.6%
Cash 18.00
18.60
36.93
37.65
34.25
36.47
24.52
47.66
70.05
82.19
growth rate 3.3% 98.6% 2.0% -9.0% 6.5% -32.8% 94.4% 47.0% 17.3%
Inventory 40.00
38.74
38.67
116.49
84.79
103.97
125.10
120.72
115.69
155.36
growth rate -3.2% -0.2% 201.3% -27.2% 22.6% 20.3% -3.5% -4.2% 34.3%
Cur.Liabilities 45.00
58.04
115.00
192.28
142.56
174.47
153.21
130.50
144.17
159.91
growth rate 29.0% 98.1% 67.2% -25.9% 22.4% -12.2% -14.8% 10.5% 10.9%
Liabilities 133.00
132.37
160.49
262.77
233.36
271.52
285.91
249.99
170.23
182.14
growth rate -0.5% 21.3% 63.7% -11.2% 16.4% 5.3% -12.6% -31.9% 7.0%
LT Debt 87.00
73.25
44.00
55.45
78.97
86.00
119.00
85.00
growth rate -15.8% -39.9% 26.0% 42.4% 8.9% 38.4% -28.6%
Equity 98.10
104.23
132.92
178.26
177.54
192.88
207.29
299.50
373.16
396.53
growth rate 6.2% 27.5% 34.1% -0.4% 8.6% 7.5% 44.5% 24.6% 6.3%
Common Shares 17.00
17.00
17.00
17.00
17.00
17.00
37.75
53.04
146.39
196.13
201.13
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 122.1% 40.5% 176.0% 34.0% 2.6%
Cash Flow Statement Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Capital Expenditures 5.00
4.66
3.63
13.85
14.50
10.77
14.74
11.68
11.02
8.54
growth rate -6.8% -22.2% 282.0% 4.7% -25.7% 36.8% -20.7% -5.7% -22.5%
Cash Dividends 15.70
18.09
22.70
57.70
58.57
49.96
39.93
9.92
4.17
15.39
growth rate 15.2% 25.5% 154.2% 1.5% -14.7% -20.1% -75.2% -57.9% 269.0%
Cash From OA 22.00
37.49
71.13
83.68
45.63
58.03
19.83
55.84
58.45
48.24
growth rate 70.4% 89.7% 17.6% -45.5% 27.2% -65.8% 181.6% 4.7% -17.5%
FCF per Share 1.33
0.49
1.70
2.82
5.32
-0.69
3.64
2.62
0.72
3.10
growth rate -63.2% 246.9% 65.9% 88.7% -100.0% 100.0% -28.0% -72.5% 330.6%
FCF 22.00
17.00
33.00
68.00
70.00
31.00
42.00
5.10
39.00
40.00
39.71
growth rate -22.7% 94.1% 106.1% 2.9% -55.7% 35.5% -87.9% 665.2% 2.6% -0.7%
Income Statement Dec '12 Jun '13 Jun '14 Jun '15 Jun '16 Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22
Sales 327.00
346.76
388.33
598.44
552.71
601.85
593.47
568.35
577.73
651.06
growth rate 6.0% 12.0% 54.1% -7.6% 8.9% -1.4% -4.2% 1.7% 12.7%
Op.Income 39.00
40.63
73.61
147.25
87.84
108.45
79.34
18.88
49.78
56.60
growth rate 4.2% 81.2% 100.1% -40.4% 23.5% -26.8% -76.2% 163.7% 13.7%
IBT 34.00
34.96
68.83
143.41
82.05
97.68
71.56
19.18
42.26
53.31
growth rate 2.8% 96.9% 108.4% -42.8% 19.1% -26.7% -73.2% 120.4% 26.1%
Net Income 25.00
25.43
46.56
100.01
59.01
70.01
53.47
15.11
28.62
30.62
growth rate 1.7% 83.1% 114.8% -41.0% 18.6% -23.6% -71.7% 89.4% 7.0%
EPS 1.46
1.48
1.49
2.69
5.76
3.40
4.06
3.09
1.04
1.48
growth rate 1.4% 0.7% 80.5% 114.1% -41.0% 19.4% -23.9% -66.3% 42.3%
Gross Profit 218.00
231.39
237.31
379.49
308.77
360.59
346.77
326.26
355.48
403.35
growth rate 6.1% 2.6% 59.9% -18.6% 16.8% -3.8% -5.9% 9.0% 13.5%
R&D 7.90
1.17
1.17
1.17
2.04
growth rate -61.5% 0.0% 0.0% 73.8%

Quarterly Statements

Item Name Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Earnings BIT 8.01
19.03
19.03
9.26
9.26
growth rate 137.7% 0.0% -51.3% 0.0%
Balance Sheet Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Acct.Receivable 120.75
125.74
125.74
121.48
121.48
growth rate 4.1% 0.0% -3.4% 0.0%
Acct.Payable 63.61
111.47
111.47
71.50
71.50
growth rate 75.2% 0.0% -35.9% 0.0%
Cur.Assets 321.63
347.11
347.11
374.45
374.45
growth rate 7.9% 0.0% 7.9% 0.0%
Total Assets 560.42
579.42
579.42
590.83
590.83
growth rate 3.4% 0.0% 2.0% 0.0%
Cash 70.05
89.38
89.38
82.19
82.19
growth rate 27.6% 0.0% -8.0% 0.0%
Inventory 115.69
121.80
121.80
155.36
155.36
growth rate 5.3% 0.0% 27.6% 0.0%
Cur.Liabilities 144.17
142.42
142.42
159.91
159.91
growth rate -1.2% 0.0% 12.3% 0.0%
Liabilities 181.47
180.10
180.10
182.14
182.14
growth rate -0.8% 0.0% 1.1% 0.0%
LT Debt
growth rate
Equity 373.16
390.34
390.34
396.53
396.53
growth rate 4.6% 0.0% 1.6% 0.0%
Common Shares 196.13
197.78
197.78
201.13
201.13
growth rate 0.8% 0.0% 1.7% 0.0%
Cash Flow Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Capital Expenditures 1.19
1.80
1.80
2.47
2.47
growth rate 50.4% 0.0% 37.6% 0.0%
Cash Dividends 2.09
3.26
3.26
4.43
4.43
growth rate 56.4% 0.0% 35.9% 0.0%
Cash From OA 6.52
17.64
17.64
6.48
6.48
growth rate 170.7% 0.0% -63.3% 0.0%
FCF 5.32
15.85
15.85
4.01
4.01
growth rate 197.7% 0.0% -74.7% 0.0%
Income Statement Jun '21 Sep '21 Dec '21 Mar '22 Jun '22
Sales 136.45
173.58
173.58
151.96
151.96
growth rate 27.2% 0.0% -12.5% 0.0%
Op.Income 8.01
19.03
19.03
9.26
9.26
growth rate 137.7% 0.0% -51.3% 0.0%
IBT 9.33
17.86
17.86
8.79
8.79
growth rate 91.5% 0.0% -50.8% 0.0%
Net Income 4.85
10.15
10.15
5.16
5.16
growth rate 109.2% 0.0% -49.2% 0.0%
Gross Profit 84.89
107.54
107.54
94.14
94.14
growth rate 26.7% 0.0% -12.5% 0.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (33.85)

YOY Growth Grade:

D (43.05)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 71.51 75.64 25.10
EPS / Growth -18.8% 1.02 23.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 16.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 13.6% 13.6%
Future PE 2.00 26.11 26.11
Future EPS 1.12 3.63 3.63
Value Price
MOS %
0.56
23.43
23.43
MOS Price 0.28 11.72 11.72
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.